Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911138 · ClinicalTrials.gov registry record · NA
Treating Complex Grammar Knowledge Deficits in School-Age Children With Developmental Language Disorder
A NA study of Developmental Language Disorders, sponsored by Ohio University.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 4
- Study locations
NCT06911138: Recruiting NA study of Developmental Language Disorders, sponsored by Ohio University.
NCT06911138 is a NA study of Developmental Language Disorders that is actively recruiting participants, run by Ohio University. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06911138, a NA study of Developmental Language Disorders, is actively recruiting participants, sponsored by Ohio University.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this project is to compare the relative effectiveness of two novel treatments to improve the complex grammar knowledge of school-age (8-11-year-old) children with developmental language disorder (DLD). Treatment 1 is an implicit approach to promoting children's automatic grammar learning and Treatment 2 is a more conventional explicit approach in which participants are taught the rules underlying the grammar. Treatment 1 involves children listening to an examiner produce a target sentence 20 times during each training session while describing a picture. The children will then see a picture and be asked to describe the action taking place. Treatment 2 involves children listening to an examiner describe the action occurring in a picture using a sentence pattern targeted to the child's deficit. The child will then be asked who did the action in the sentence and who received the action, after which the examiner will provide specific feedback about why the child's response was correct or incorrect. The expectation is that over a short period children will begin to use their targeted sentence pattern after hearing the examiner produce it many times. Children will complete four outcome measures (syntactic knowledge, sentence comprehension, sentence chunking, narrative comprehension/ production) prior to treatment, immediately after treatment, and five weeks after treatment. Children will be randomly assigned to one of the two treatments. Both treatments will be delivered 20 times over 10 weeks. The investigators anticipate that the children receiving Treatment 1 will show stronger gains in knowledge across the four outcome measures.
Primary Outcome
This measure assesses participants' comprehension of subject-object and passive sentences in a conventional picture pointing task, i.e., listening to a sentence then pointing to an image that best depicts what is stated in the sentence. The dependent variable is percent accuracy (0% - 100%).
Conditions Studied
Interventions
- BEHAVIORAL Behavorial
Study Locations (4)
Arizona
- University of Arizona - Tucson
Ohio
- Ohio University - Athens
Utah
- Utah State University - Logan
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2027-10-15 |
| Phase | NA |
What NCT06911138 shows while recruiting
NCT06911138 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Developmental Language Disorders appearing as the primary indexed condition, and to 1 intervention - of which Behavorial is the first listed.
NCT06911138 reports a single indexed study location in Arizona, Ohio, Utah.
Frequently Asked Questions
What is clinical trial NCT06911138 about?
NCT06911138 is a clinical study titled "Treating Complex Grammar Knowledge Deficits in School-Age Children With Developmental Language Disorder". The goal of this project is to compare the relative effectiveness of two novel treatments to improve the complex grammar knowledge of school-age (8-11-year-old) children with developmental language disorder (DLD). Treatment 1 is an implicit approach to promoting children's automatic grammar learning...
What is the current status of trial NCT06911138?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-12-01. Estimated completion is 2027-10-15.
What conditions does trial NCT06911138 study?
This clinical trial studies the following conditions: Developmental Language Disorders.
What interventions are being tested in trial NCT06911138?
The interventions under investigation include: Behavorial (BEHAVIORAL).
Who is sponsoring clinical trial NCT06911138?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911138 being conducted?
This trial has 4 study locations across Arizona, Ohio, Utah, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06911138's enrollment target sits among peer trials
150 661st of 2000 higher than 1,300 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI